Time after surgery to post‐void residual volume of urine ≤ 50 mL (days)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Post‐void residual urine volume (mL) at 1 month after surgery
1 finding from 1 review
Urinary tract infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of spontaneous voiding recovery 1 week after surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Short‐term lymphocyst formation: both asymptomatic and symptomatic within 4 weeks after surgery · patients with gynaecological malignancies
Retroperitoneal drainage showed no clear difference in short‐term lymphocyst formation: both asymptomatic and symptomatic… compared with no drainage after pelvic lymphadenectomy (moderate certainty).
1 finding from 1 review
Short‐term lymphocyst formation: symptomatic within 4 weeks after surgery · patients with gynaecological malignancies
Retroperitoneal drainage leads to higher short‐term lymphocyst formation: symptomatic within 4 weeks after… compared with no drainage after pelvic lymphadenectomy (high certainty).
1 finding from 1 review
Short‐term lymphocyst formation: both asymptomatic and symptomatic at 8 weeks after surgery · patients with gynaecological malignancies
Retroperitoneal drainage showed no clear difference in short‐term lymphocyst formation: both asymptomatic and symptomatic… compared with no drainage after pelvic lymphadenectomy (high certainty).
1 finding from 1 review
Long‐term lymphocyst formation: both asymptomatic and symptomatic at 12 months after surgery · patients with gynaecological malignancies
Retroperitoneal drainage showed no clear difference in long‐term lymphocyst formation: both asymptomatic and symptomatic at… compared with no drainage after pelvic lymphadenectomy (high certainty).
1 finding from 1 review
Long‐term lymphocyst formation: symptomatic at 12 months after surgery · patients with gynaecological malignancies
Retroperitoneal drainage showed no clear difference in long‐term lymphocyst formation: symptomatic at 12 months after surgery compared with no drainage after pelvic lymphadenectomy (low certainty).
1 finding from 1 review
Intervention not reported
Surgery‐related systemic morbidity · women with stage I endometrial cancer
The intervention probably leads to higher surgery‐related systemic morbidity (moderate certainty).
1 finding from 1 review
Menopause‐specific quality of life (quality of life) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Effect on later sexual function · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
Body image · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Sexual self‐efficacy scale · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
Sexual knowledge · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
Participant satisfaction · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
Effect on later sexual function · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Sexual distress (sexual distress) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Vasomotor symptoms (vasomotor) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Measures of psychosocial factors · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review